Labatec Pharma SA
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 1957-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.labatecpharma.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- First Posted Date
- 2018-02-15
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- Labatec Pharma SA
- Target Recruit Count
- 80
- Registration Number
- NCT03435094
- Locations
- 🇨🇭
Endokrinologische Praxis & Labor, Basel, BS, Switzerland
🇨🇭Hôpital Universitaire de Genève, Service des maladies osseuses, Genève, GE, Switzerland
News
No news found